BICX — BioCorRx Inc.
—
OTC ·
Health Care ·
Health Care Providers & Services ·
CIK 1443863 ·
Last close
$0.20
Market Cap
$5.98M
52W High
$1.28
52W Low
$0.15
ADV30
2,910
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 87,970 | -56,997 | -786,061 | -964,774 | 1,907,459 | 21,237 | 14,379,077 |
| Mar 2026 | 214,539 | 189,355 | -587,029 | -831,227 | 2,324,865 | 211,911 | 13,948,134 |
| Dec 2025 | -151,118 | 185,893 | 466,284 | 552,555 | 2,147,212 | 139,360 | 13,674,200 |
| Sep 2025 | 635,224 | 276,412 | -1,078,457 | -1,917,873 | 7,533,473 | 287,688 | 20,297,768 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,041,639
Investing CF
—
Financing CF
$2,229,408
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.27
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-87,480,515
Inventory
$143,425
Receivables
$452,068
ST Investments
—
EBIT TTM
$-2,736,454
Pretax Income TTM
$-3,516,888
Interest Exp TTM
$780,434
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$651,145
EBITDA
$-5,077,928
Free Cash Flow
$-7,918,811
Enterprise Value
$9,491,676
Total Cash
$21,237
Total Debt
$2,298,535
Shares Out
29,758,177
Trailing EPS
$-0.13
Book Value
$-0.41
ROE
—
ROA
-73.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 797,244 | -2,395,794 | -3,440,146 | 2,147,212 | 13,674,200 | -11,223,559 | -2,298,291 |
| Dec 2024 | 7,665 | -3,649,229 | -5,106,124 | 385,941 | 12,741,173 | -12,120,420 | -1,096,254 |
| Dec 2023 | 89,160 | -2,806,820 | -3,766,913 | 388,887 | 10,341,411 | -9,823,690 | -1,853,282 |
| Dec 2022 | 213,841 | -2,908,499 | -4,369,413 | 766,594 | 8,968,325 | -8,076,474 | -2,041,773 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$659
NetIncome TTM
$-6,752
OpCashFlow TTM
$0
Assets (Latest)
$4,061,511
Forward EPS
$-0.07
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HLYK | HealthLynked Corp | $5.81M | $1.97 | — |
| BMGL | Basel Medical Group Ltd | $5.79M | $3.70 | — |
| CDIX | Cardiff Lexington Corp | $6.57M | $0.42 | — |
| ACON | Aclarion, Inc. | $7.47M | $2.59 | — |
| XCRT | Xcelerate, Inc. | $8.69M | $0.02 | — |
News headlines (Yahoo Finance, 1h cache)
BioCorRx Inc. Appoints Former Acting White House Drug Policy Director Richard J. Baum to Strategic Advisory Board
2026-09-10 09:16 · Yahoo
BioCorRx Announces National Drug Codes (NDCs) for LUCEMYRA (lofexidine) Brand and Authorized Generic (AG) SKUs to Ensure Uninterrupted Market Supply
2026-08-25 12:17 · Yahoo
BioCorRx, Inc. Announces Issuance of U.S. Patent Supporting Its Biodegradable Naltrexone Implant Technology
2026-03-11 12:30 · Yahoo
BioCorRx, Inc. Announces Initiation of Clinical Study by Majority-Owned Subsidiary BioCorRx Pharmaceuticals, Inc. Evaluating Long-Acting Naltrexone Implant With or Without Bupropion
2026-01-14 13:30 · Yahoo
BioCorRx Announces Appointment of Louis Lucido as Board Chair
2026-01-06 13:30 · Yahoo
BioCorRx Provides Update on OTC Markets Quotation Status and Planned Form S1 Filing
2025-12-24 13:30 · Yahoo
Life Sciences Virtual Investor Forum Agenda Announced for December 11th
2025-12-09 13:35 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.